Skip to main content
Top
Published in: Cardiology and Therapy 1/2017

Open Access 01-06-2017 | Case Series

Subclinical Right Ventricular Dysfunction in Patients with Severe Aortic Stenosis: A Retrospective Case Series

Authors: Dagmar F. Hernandez-Suarez, Angel López-Candales

Published in: Cardiology and Therapy | Issue 1/2017

Login to get access

Abstract

Introduction

There is scarce information about right ventricle (RV) function in patients with secondary pulmonary hypertension (PH) undergoing transcatheter aortic valve implantation (TAVI). We aim to identify possible RV abnormalities in patients referred for TAVI with severe aortic stenosis (sAS) and secondary PH.

Methods

Objective measures of RV function, as well as noninvasive estimates of pulmonary artery systolic pressures (PASP) were obtained from 30 sAS patients undergoing percutaneous valve intervention.

Results

Sixteen (53%) evaluated patients had some degree of PH. As expected, left ventricular mass index (281 ± 75 g/m2) and left atrial volume index (89 ± 23 mL/m2) values were significantly elevated. Even though RV end-systolic (8 ± 4 cm2) and end-diastolic (17 ± 4 cm2) areas were normal as well as RV fractional area change values (57 ± 16%); both longitudinal measures of RV systolic function such as tricuspid annular plane systolic excursion (1.9 ± 0.5 cm) and systolic velocity (10 ± 2 cm/s) were clearly reduced with just mild elevations in PASP (54 ± 7 mmHg).

Conclusions

Subclinical RV dysfunction is present in patients with sAS and secondary PH undergoing TAVI. Whether longitudinal measures of RV systolic function could predict clinical outcomes in these patients needs to be further explored.
Literature
1.
go back to reference Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28(2):230–68.PubMed Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28(2):230–68.PubMed
2.
go back to reference Lung B, Cachier A, Baron G, et al. Decision-making in elderly patient with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24):2714–20.CrossRef Lung B, Cachier A, Baron G, et al. Decision-making in elderly patient with severe aortic stenosis: why are so many denied surgery? Eur Heart J. 2005;26(24):2714–20.CrossRef
3.
go back to reference Gargiulo G, Sannino A, Capodanno D, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a systematic review and meta-analysis. Ann Intern Med. 2016;165(5):334–44.CrossRefPubMed Gargiulo G, Sannino A, Capodanno D, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement: a systematic review and meta-analysis. Ann Intern Med. 2016;165(5):334–44.CrossRefPubMed
5.
go back to reference Pai RG, Varadarajan P, Kapoor N, Bansal RC. Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg. 2007;84(1):80–5.CrossRefPubMed Pai RG, Varadarajan P, Kapoor N, Bansal RC. Aortic valve replacement improves survival in severe aortic stenosis associated with severe pulmonary hypertension. Ann Thorac Surg. 2007;84(1):80–5.CrossRefPubMed
6.
go back to reference Luçon A, Oger E, Bedossa M, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 registry. Circ Cardiovasc Interv. 2014;7(2):240–7.CrossRefPubMed Luçon A, Oger E, Bedossa M, et al. Prognostic implications of pulmonary hypertension in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation: study from the FRANCE 2 registry. Circ Cardiovasc Interv. 2014;7(2):240–7.CrossRefPubMed
7.
go back to reference Zlotnick DM, Ouellette ML, Malenka DJ, et al. Effect of preoperative pulmonary hypertension on outcomes in patients with severe aortic stenosis following surgical aortic valve replacement. Am J Cardiol. 2013;112(10):1635–40.CrossRefPubMed Zlotnick DM, Ouellette ML, Malenka DJ, et al. Effect of preoperative pulmonary hypertension on outcomes in patients with severe aortic stenosis following surgical aortic valve replacement. Am J Cardiol. 2013;112(10):1635–40.CrossRefPubMed
8.
go back to reference López-Candales A, Lopez FR, Trivedi S, Elwing J. Right ventricular ejection efficiency: a new echocardiographic measure of mechanical performance in chronic pulmonary hypertension. Echocardiography. 2014;31(4):516–23.CrossRefPubMed López-Candales A, Lopez FR, Trivedi S, Elwing J. Right ventricular ejection efficiency: a new echocardiographic measure of mechanical performance in chronic pulmonary hypertension. Echocardiography. 2014;31(4):516–23.CrossRefPubMed
9.
go back to reference Silver K, Aurigemma G, Krendel S, Barry N, Ockene I, Alpert J. Pulmonary artery hypertension in severe aortic stenosis: incidence and mechanism. Am Heart J. 1993;125:146–50.CrossRefPubMed Silver K, Aurigemma G, Krendel S, Barry N, Ockene I, Alpert J. Pulmonary artery hypertension in severe aortic stenosis: incidence and mechanism. Am Heart J. 1993;125:146–50.CrossRefPubMed
10.
go back to reference Barbash IM, Escarcega RO, Minha S, et al. Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement. Am J Cardiol. 2015;115(10):1435–42.CrossRefPubMed Barbash IM, Escarcega RO, Minha S, et al. Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement. Am J Cardiol. 2015;115(10):1435–42.CrossRefPubMed
11.
go back to reference Musa TA, Uddin A, Fairbairn TA, et al. Right ventricular function following surgical aortic valve replacement and transcatheter aortic valve implantation: a cardiovascular MR study. Int J Cardiol. 2016;223:639–44.CrossRefPubMed Musa TA, Uddin A, Fairbairn TA, et al. Right ventricular function following surgical aortic valve replacement and transcatheter aortic valve implantation: a cardiovascular MR study. Int J Cardiol. 2016;223:639–44.CrossRefPubMed
12.
go back to reference López-Candales A, Rajagopalan N, Gulyasy B, Edelman K, Bazaz R. Comparative echocardiographic analysis of mitral and tricuspid annular motion: differences explained with proposed anatomic–structural correlates. Echocardiography. 2007;24(4):353–9.CrossRefPubMed López-Candales A, Rajagopalan N, Gulyasy B, Edelman K, Bazaz R. Comparative echocardiographic analysis of mitral and tricuspid annular motion: differences explained with proposed anatomic–structural correlates. Echocardiography. 2007;24(4):353–9.CrossRefPubMed
13.
go back to reference Bazaz R, Edelman K, Gulyasy B, López-Candales A. Evidence of robust coupling of atrioventricular mechanical function of the right side of the heart: insights from M-mode analysis of annular motion. Echocardiography. 2008;25(6):557–61.CrossRefPubMed Bazaz R, Edelman K, Gulyasy B, López-Candales A. Evidence of robust coupling of atrioventricular mechanical function of the right side of the heart: insights from M-mode analysis of annular motion. Echocardiography. 2008;25(6):557–61.CrossRefPubMed
Metadata
Title
Subclinical Right Ventricular Dysfunction in Patients with Severe Aortic Stenosis: A Retrospective Case Series
Authors
Dagmar F. Hernandez-Suarez
Angel López-Candales
Publication date
01-06-2017
Publisher
Springer Healthcare
Published in
Cardiology and Therapy / Issue 1/2017
Print ISSN: 2193-8261
Electronic ISSN: 2193-6544
DOI
https://doi.org/10.1007/s40119-017-0084-8

Other articles of this Issue 1/2017

Cardiology and Therapy 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.